LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 145

Suchoptionen

  1. Artikel ; Online: Improving "may contain" labels: A call to team up and share data.

    Turner, Paul J / Eiwegger, Thomas

    Allergy

    2024  

    Sprache Englisch
    Erscheinungsdatum 2024-01-12
    Erscheinungsland Denmark
    Dokumenttyp Editorial
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.16012
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Defining the questions to be asked in severe asthma trials: data from the COMSA working group.

    Eiwegger, Thomas / Bendien, Sarah A

    The European respiratory journal

    2023  Band 61, Heft 4

    Mesh-Begriff(e) Humans ; Child ; Adult ; Asthma/drug therapy ; Outcome Assessment, Health Care
    Sprache Englisch
    Erscheinungsdatum 2023-04-03
    Erscheinungsland England
    Dokumenttyp Editorial ; Comment
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.02058-2022
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Introducing peanut early in life - Ready for the general population?

    Szépfalusi, Zsolt / Eiwegger, Thomas

    Allergy

    2023  Band 78, Heft 5, Seite(n) 1142–1144

    Mesh-Begriff(e) Humans ; Arachis/adverse effects ; Peanut Hypersensitivity/diagnosis ; Peanut Hypersensitivity/epidemiology ; Desensitization, Immunologic
    Sprache Englisch
    Erscheinungsdatum 2023-03-30
    Erscheinungsland Denmark
    Dokumenttyp Editorial
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15676
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: An alternative path to oral tolerance.

    Li, Carmen H / Kabak, Ekaterina / Eiwegger, Thomas

    Allergy

    2023  Band 78, Heft 7, Seite(n) 2058–2060

    Mesh-Begriff(e) Humans ; Food Hypersensitivity ; Dendritic Cells ; Immune Tolerance ; Allergens ; Administration, Oral ; T-Lymphocytes, Regulatory
    Chemische Substanzen Allergens
    Sprache Englisch
    Erscheinungsdatum 2023-03-16
    Erscheinungsland Denmark
    Dokumenttyp News
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15701
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Avoiding avoidance in milk and egg allergy.

    Wong, Dennis / Eiwegger, Thomas / Upton, Julia E M

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

    2022  Band 129, Heft 6, Seite(n) 657–658

    Mesh-Begriff(e) Humans ; Animals ; Egg Hypersensitivity ; Milk
    Sprache Englisch
    Erscheinungsdatum 2022-12-01
    Erscheinungsland United States
    Dokumenttyp Editorial ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 1228189-x
    ISSN 1534-4436 ; 0003-4738 ; 1081-1206
    ISSN (online) 1534-4436
    ISSN 0003-4738 ; 1081-1206
    DOI 10.1016/j.anai.2022.09.019
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Oral immunotherapy for food allergy: What's age got to do with it?

    Upton, Julia E M / Correa, Natasha / Eiwegger, Thomas

    Allergy

    2022  Band 78, Heft 3, Seite(n) 626–628

    Mesh-Begriff(e) Humans ; Food Hypersensitivity/therapy ; Anaphylaxis/drug therapy ; Immunotherapy ; Allergens/therapeutic use ; Desensitization, Immunologic ; Administration, Oral
    Chemische Substanzen Allergens
    Sprache Englisch
    Erscheinungsdatum 2022-12-21
    Erscheinungsland Denmark
    Dokumenttyp Editorial
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15623
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Management of allergic diseases in pregnancy.

    Pfaller, Birgit / Bendien, Sarah / Ditisheim, Agnès / Eiwegger, Thomas

    Allergy

    2021  Band 77, Heft 3, Seite(n) 798–811

    Abstract: Allergic diseases like asthma, allergic rhinitis, food allergy, hymenoptera allergy, or atopic dermatitis are highly prevalent in women of childbearing age and may affect up to 30% of this age group. This review focuses on the management of allergic ... ...

    Abstract Allergic diseases like asthma, allergic rhinitis, food allergy, hymenoptera allergy, or atopic dermatitis are highly prevalent in women of childbearing age and may affect up to 30% of this age group. This review focuses on the management of allergic diseases during pregnancy. Furthermore, we discuss the challenges of counseling women with allergic diseases in the reproductive age, including considerations relevant to the ongoing SARS-CoV-2 pandemic. To create the optimal milieu for the unborn child, a multitude of immunological changes occur during pregnancy which may favor type 2 responses and aggravate disease phenotypes. In co-occurrence with suboptimal preconception disease control, this elevated Th2 responses may aggravate allergic disease manifestations during pregnancy and pose a risk for mother and child. Due to limitations in conducting clinical trials in pregnant women, safety data on anti-allergic drugs during pregnancy are limited. The lack of information and concerns among pregnant patients demands counseling on the benefits of anti-allergic drugs and the potential and known risks. This includes information on the risk for mother and child of disease aggravation in the absence of treatment. By doing so, informed decisions and shared decision-making can take place.
    Mesh-Begriff(e) COVID-19 ; Dermatitis, Atopic ; Female ; Food Hypersensitivity ; Humans ; Pregnancy ; Rhinitis, Allergic ; SARS-CoV-2
    Sprache Englisch
    Erscheinungsdatum 2021-09-04
    Erscheinungsland Denmark
    Dokumenttyp Journal Article ; Review
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15063
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: An update on recent developments and highlights in food allergy.

    Locke, Arielle / Hung, Lisa / Upton, Julia E M / O'Mahony, Liam / Hoang, Jennifer / Eiwegger, Thomas

    Allergy

    2023  Band 78, Heft 9, Seite(n) 2344–2360

    Abstract: While both the incidence and general awareness of food allergies is increasing, the variety and clinical availability of therapeutics remain limited. Therefore, investigations into the potential factors contributing to the development of food allergy (FA) ...

    Abstract While both the incidence and general awareness of food allergies is increasing, the variety and clinical availability of therapeutics remain limited. Therefore, investigations into the potential factors contributing to the development of food allergy (FA) and the mechanisms of natural tolerance or induced desensitization are required. In addition, a detailed understanding of the pathophysiology of food allergies is needed to generate compelling, enduring, and safe treatment options. New findings regarding the contribution of barrier function, the effect of emollient interventions, mechanisms of allergen recognition, and the contributions of specific immune cell subsets through rodent models and human clinical studies provide novel insights. With the first approved treatment for peanut allergy, the clinical management of FA is evolving toward less intensive, alternative approaches involving fixed doses, lower maintenance dose targets, coadministration of biologicals, adjuvants, and tolerance-inducing formulations. The ultimate goal is to improve immunotherapy and develop precision-based medicine via risk phenotyping allowing optimal treatment for each food-allergic patient.
    Mesh-Begriff(e) Humans ; Food Hypersensitivity/therapy ; Food ; Peanut Hypersensitivity ; Allergens ; Immunotherapy ; Desensitization, Immunologic
    Chemische Substanzen Allergens
    Sprache Englisch
    Erscheinungsdatum 2023-05-12
    Erscheinungsland Denmark
    Dokumenttyp Journal Article ; Review
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15749
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: An update on recent developments and highlights in food allergy

    Locke, Arielle / Hung, Lisa / Upton, Julia E. M. / O'Mahony, Liam / Hoang, Jennifer / Eiwegger, Thomas

    Allergy. 2023 Sept., v. 78, no. 9, p. 2344-2360

    2023  , Seite(n) 2344–2360

    Abstract: While both the incidence and general awareness of food allergies is increasing, the variety and clinical availability of therapeutics remain limited. Therefore, investigations into the potential factors contributing to the development of food allergy (FA) ...

    Abstract While both the incidence and general awareness of food allergies is increasing, the variety and clinical availability of therapeutics remain limited. Therefore, investigations into the potential factors contributing to the development of food allergy (FA) and the mechanisms of natural tolerance or induced desensitization are required. In addition, a detailed understanding of the pathophysiology of food allergies is needed to generate compelling, enduring, and safe treatment options. New findings regarding the contribution of barrier function, the effect of emollient interventions, mechanisms of allergen recognition, and the contributions of specific immune cell subsets through rodent models and human clinical studies provide novel insights. With the first approved treatment for peanut allergy, the clinical management of FA is evolving toward less intensive, alternative approaches involving fixed doses, lower maintenance dose targets, coadministration of biologicals, adjuvants, and tolerance‐inducing formulations. The ultimate goal is to improve immunotherapy and develop precision‐based medicine via risk phenotyping allowing optimal treatment for each food‐allergic patient.
    Schlagwörter allergens ; food allergies ; humans ; immunotherapy ; medicine ; pathophysiology ; patients ; peanuts ; phenotype ; risk ; rodents
    Sprache Englisch
    Erscheinungsverlauf 2023-09
    Umfang p. 2344-2360
    Erscheinungsort John Wiley & Sons, Ltd
    Dokumenttyp Artikel ; Online
    Anmerkung REVIEW
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15749
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Oral peanut immunotherapy How much is too much? How much is enough?

    Bluemchen, Katharina / Eiwegger, Thomas

    Allergy

    2018  Band 74, Heft 2, Seite(n) 220–222

    Mesh-Begriff(e) Arachis ; Child ; Desensitization, Immunologic ; Feasibility Studies ; Humans ; Peanut Hypersensitivity
    Sprache Englisch
    Erscheinungsdatum 2018-10-23
    Erscheinungsland Denmark
    Dokumenttyp Editorial ; Comment
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.13644
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang